Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands
about
Druggability Assessment of Allosteric Proteins by Dynamics Simulations in the Presence of Probe MoleculesTargeting the PTPome in human disease.Protein tyrosine phosphatases: structure-function relationships.Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis.Fragment-based drug discovery using the SHAPES method.Potent and selective inhibition of T-cell protein tyrosine phosphatase (TCPTP) by a dinuclear copper(II) complex.Investigating the impact of Asp181 point mutations on interactions between PTP1B and phosphotyrosine substrate.Ligand efficiency indices for effective drug discovery.Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents.Metabolic diseases drug discovery world summit. July 28-29, 2003, San Diego, CA, USA.Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase beta.Challenging the gold standard for 3D-QSAR: template CoMFA versus X-ray alignment.Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations.Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.Michael addition/pericyclization/rearrangement--a multicomponent strategy for the synthesis of substituted resorcinols.
P2860
Q24633124-D5288887-26BC-4BCD-97AF-3FBBD960BAA9Q36379394-28EB4060-3611-4B1F-ADB2-772C95BAE770Q37094073-C9C6FB46-EE9D-4D19-854E-C62259929A64Q37855897-A4F5BEC0-CEB9-4963-985E-11459243A1C0Q38017355-F8110F86-E1FF-43F4-977D-C1FD7BA3DC28Q38089130-A098AAD8-8DA7-4A66-9DC1-938089E7E233Q39429947-614AFF76-2385-46F8-B0DF-5AA037D3090FQ39983222-3F87C5E5-1B62-4660-B7F8-1C66BCAD4F6CQ40228492-B47E1640-7A99-4C3C-8676-156C893FF702Q43117913-0AC67D91-AF58-43FD-BADF-16CF0E17BDBBQ44602414-1D68260F-7B93-49B9-9D3B-353BB2F973D6Q44801456-26A79530-5C1F-48D3-82DB-B886E95D9DA8Q46627471-CD569033-9EB9-4697-B1A2-11C893F7D87EQ47629500-F586AA69-77FD-4457-AFBA-9E37537AFA9CQ51359048-333E0D85-F24F-420D-835F-EEEE58704559Q53370454-1B4ED3F3-9C75-4D7F-B6F5-95CBF6AB6023
P2860
Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@ast
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@en
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@nl
type
label
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@ast
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@en
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@nl
prefLabel
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@ast
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@en
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@nl
P2093
P356
P1476
Selective protein tyrosine pho ...... oxylic acid-containing ligands
@en
P2093
Bruce G Szczepankiewicz
Cathy E Berg
Cele Abad-Zapatero
Charles W Hutchins
Cristina M Rondinone
David A Janowick
Heng Liang
James M Trevillyan
Michael A Stashko
P304
P356
10.1021/JM034088D
P407
P577
2003-07-31T00:00:00Z